Entrada Therapeutics, Inc. insider trading activity
Understanding Insider Activity at Entrada Therapeutics, Inc.
Welcome to our dedicated page for Entrada Therapeutics, Inc. (Nasdaq: TRDA) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Entrada Therapeutics, Inc.'s key insiders, providing a unique window into the company's internal sentiments.
How to Use This Data:
Below, you can view insider transactions that were reported to the SEC within the last 365 days.
While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.
Scroll down to view the most recent insider transactions for Entrada Therapeutics, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.
Track insider trades for TRDATicker | Time & Date | Filing | Link |
---|---|---|---|
TRDA | 9:49:06 PM 11/13/2024 | Sethuraman Natarajan(President, Research & Develop.) sold 4109 shares of Entrada Therapeutics, Inc. (TRDA) for ~$82302 | Filing |
TRDA | 9:47:06 PM 11/13/2024 | WENTWORTH KORY JAMES(Chief Financial Officer) sold 8637 shares of Entrada Therapeutics, Inc. (TRDA) for ~$172567 | Filing |
TRDA | 9:36:50 PM 11/6/2024 | Sethuraman Natarajan(President, Research & Develop.) sold 18219 shares of Entrada Therapeutics, Inc. (TRDA) for ~$339292 | Filing |
TRDA | 8:31:39 PM 10/18/2024 | Sethuraman Natarajan(President, Research & Develop.) sold 600 shares of Entrada Therapeutics, Inc. (TRDA) for ~$10800 | Filing |
TRDA | 8:32:11 PM 9/30/2024 | Dowden Nathan J(President & COO) sold 847 shares of Entrada Therapeutics, Inc. (TRDA) for ~$13552 | Filing |
TRDA | 8:34:51 PM 9/10/2024 | WENTWORTH KORY JAMES(Chief Financial Officer) sold 3195 shares of Entrada Therapeutics, Inc. (TRDA) for ~$47829 | Filing |
TRDA | 8:33:34 PM 9/10/2024 | Dowden Nathan J(President & COO) sold 2303 shares of Entrada Therapeutics, Inc. (TRDA) for ~$34753 | Filing |
TRDA | 8:32:12 PM 9/10/2024 | Sethuraman Natarajan(Chief Scientific Officer) sold 3242 shares of Entrada Therapeutics, Inc. (TRDA) for ~$49011 | Filing |
TRDA | 8:33:43 PM 8/20/2024 | Dowden Nathan J(President & COO) sold 27097 shares of Entrada Therapeutics, Inc. (TRDA) for ~$440817 | Filing |
TRDA | 8:43:46 PM 7/16/2024 | Sethuraman Natarajan(Chief Scientific Officer) sold 1238 shares of Entrada Therapeutics, Inc. (TRDA) for ~$22284 | Filing |
TRDA | 8:42:17 PM 7/16/2024 | Doshi Dipal(CEO) sold 1900 shares of Entrada Therapeutics, Inc. (TRDA) for ~$33896 | Filing |
TRDA | 8:34:42 PM 7/10/2024 | WENTWORTH KORY JAMES(Chief Financial Officer) sold 1758 shares of Entrada Therapeutics, Inc. (TRDA) for ~$26282 | Filing |
TRDA | 8:32:12 PM 6/14/2024 | Doshi Dipal(CEO) sold 1000 shares of Entrada Therapeutics, Inc. (TRDA) for ~$16170 | Filing |
TRDA | 9:26:05 PM 5/20/2024 | Sethuraman Natarajan(Chief Scientific Officer) sold 18980 shares of Entrada Therapeutics, Inc. (TRDA) for ~$287700 | Filing |
TRDA | 9:21:58 PM 5/20/2024 | Doshi Dipal(CEO) sold 3000 shares of Entrada Therapeutics, Inc. (TRDA) for ~$45132 | Filing |
TRDA | 8:33:48 PM, 5/16/2024 | KIM PETER S purchased 25000 shares of Entrada Therapeutics, Inc. (TRDA) for ~$364750 | Filing |
TRDA | 12:00:01 AM, 5/10/2024 | KIM PETER S purchased 4476 shares of Entrada Therapeutics, Inc. (TRDA) for ~$63305 | Filing |
TRDA | 8:35:18 PM, 4/10/2024 | KIM PETER S purchased 2600 shares of Entrada Therapeutics, Inc. (TRDA) for ~$35282 | Filing |
TRDA | 8:31:27 PM, 4/1/2024 | KIM PETER S purchased 1512 shares of Entrada Therapeutics, Inc. (TRDA) for ~$20790 | Filing |
TRDA | 9:57:20 PM, 3/26/2024 | KIM PETER S purchased 9048 shares of Entrada Therapeutics, Inc. (TRDA) for ~$122897 | Filing |
TRDA | 8:31:20 PM, 3/21/2024 | KIM PETER S purchased 2732 shares of Entrada Therapeutics, Inc. (TRDA) for ~$34994 | Filing |
TRDA | 9:36:21 PM 3/8/2024 | WENTWORTH KORY JAMES(Chief Financial Officer) sold 4086 shares of Entrada Therapeutics, Inc. (TRDA) for ~$50298 | Filing |
TRDA | 9:34:26 PM 3/8/2024 | Dowden Nathan J(President & COO) sold 1826 shares of Entrada Therapeutics, Inc. (TRDA) for ~$22496 | Filing |
TRDA | 9:37:38 PM 2/20/2024 | Doshi Dipal(CEO) sold 1000 shares of Entrada Therapeutics, Inc. (TRDA) for ~$15000 | Filing |
TRDA | 9:32:35 PM 1/18/2024 | Doshi Dipal(CEO) sold 1000 shares of Entrada Therapeutics, Inc. (TRDA) for ~$15990 | Filing |
Discover the Complete Picture 🔒
Currently viewing just 6 of 61 insider filings.
Register now to dive deeper and explore the full dataset.